Paper15123779
Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.
Mitsuhashi M and 4 others. J Leukoc Biol, 2004. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. Papers, record 15123779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15123779
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Dinoprostone | Major topic |
| Interleukin-12 | Major topic |
| Mammary Neoplasms, Animal | Major topic |
| Animals | |
| Cyclooxygenase 2 | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Isoenzymes | |
| Macrophages | |
| Mice | |
| Prostaglandin-Endoperoxide Synthases | |
| RNA, Messenger |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI045899 | NIAID NIH HHS | United States | R01AI045899 | PubMed and NIH | NIH RePORTER |
| R01 CA100223 | NCI NIH HHS | United States | R01CA100223 | PubMed and NIH | NIH RePORTER |
| AI45899 | NIAID NIH HHS | United States | R01AI045899 | PubMed and NIH | NIH RePORTER |
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,811,310 | Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). | J Natl Cancer Inst | 1998 | https://conductscience.org/library/papers/9811310 | PubMed |
| 2 | 9,818,793 | Regulation of monocyte IL-12 production: augmentation by lymphocyte contact and acute ethanol treatment, inhibition by elevated intracellular cAMP. | Int J Immunopharmacol | 1998 | https://conductscience.org/library/papers/9818793 | PubMed |
| 3 | 9,862,429 | Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages. | FEBS Lett | 1998 | https://conductscience.org/library/papers/9862429 | PubMed |
| 4 | 9,927,056 | Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. | Cancer Res | 1999 | https://conductscience.org/library/papers/9927056 | PubMed |
| 5 | 10,087,650 | Interleukin-12: basic principles and clinical applications. | Curr Top Microbiol Immunol | 1999 | https://conductscience.org/library/papers/10087650 | PubMed |
| 6 | 10,419,880 | Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. | Blood | 1999 | https://conductscience.org/library/papers/10419880 | PubMed |
| 7 | 10,455,890 | Deficiency of the transcription factor c-fos increases lipopolysaccharide-induced macrophage interleukin 12 production. | Surgery | 1999 | https://conductscience.org/library/papers/10455890 | PubMed |
| 8 | 10,469,049 | Interferon-gamma (IFN-gamma) and prostaglandin E2 (PGE2) regulate differently IL-12 production in human intestinal lamina propria mononuclear cells (LPMC). | Clin Exp Immunol | 1999 | https://conductscience.org/library/papers/10469049 | PubMed |
| 9 | 10,508,233 | Prostanoid receptors: structures, properties, and functions. | Physiol Rev | 1999 | https://conductscience.org/library/papers/10508233 | PubMed |
| 10 | 9,099,678 | Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9099678 | PubMed |
| 11 | 10,542,221 | Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10542221 | PubMed |
| 12 | 10,605,031 | Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. | J Immunol | 2000 | https://conductscience.org/library/papers/10605031 | PubMed |
| 13 | 10,623,821 | Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. | J Immunol | 2000 | https://conductscience.org/library/papers/10623821 | PubMed |
| 14 | 10,632,329 | Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer. | Clin Cancer Res | 1999 | https://conductscience.org/library/papers/10632329 | PubMed |
| 15 | 10,447,723 | Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. | Immunology | 1999 | https://conductscience.org/library/papers/10447723 | PubMed |
| 16 | 10,799,905 | Prostaglandin E2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A. | J Immunol | 2000 | https://conductscience.org/library/papers/10799905 | PubMed |
| 17 | 10,815,886 | Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response. | Clin Cancer Res | 2000 | https://conductscience.org/library/papers/10815886 | PubMed |
| 18 | 10,825,375 | NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). | Mol Hum Reprod | 2000 | https://conductscience.org/library/papers/10825375 | PubMed |
| 19 | 10,857,848 | Suppression of T cell function: a potential role for transcriptional repressor ICER. | J Leukoc Biol | 2000 | https://conductscience.org/library/papers/10857848 | PubMed |
| 20 | 10,880,012 | Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism. | Cancer Gene Ther | 2000 | https://conductscience.org/library/papers/10880012 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,099,847 | Inhibition of junctional protein disruption by 2,4,6-trihydroxy-3-geranyl acetophenone in lipopolysaccharide-induced endothelial hyperpermeability via GEF-H1/RhoA/ROCK pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41099847 | PubMed |
| 41,051,138 | Radiolabelled Cyclodextrins for the Positron Emission Tomography Imaging of Breast Cancer: Preclinical Perspectives. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/41051138 | PubMed |
| 32,751,993 | Anti-Inflammatory Polymeric Nanoparticles Based on Ketoprofen and Dexamethasone. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32751993 | PubMed |
| 31,635,311 | Anti-Cancer Effects of Synergistic Drug-Bacterium Combinations on Induced Breast Cancer in BALB/c Mice. | Biomolecules | 2019 | https://conductscience.org/library/papers/31635311 | PubMed |
| 30,248,985 | Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30248985 | PubMed |
| 29,494,692 | IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55-/- mice. | PLoS One | 2018 | https://conductscience.org/library/papers/29494692 | PubMed |
| 26,918,147 | Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. | F1000Res | 2015 | https://conductscience.org/library/papers/26918147 | PubMed |
| 26,167,490 | Mushroom β-Glucan May Immunomodulate the Tumor-Associated Macrophages in the Lewis Lung Carcinoma. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26167490 | PubMed |
| 24,514,955 | Interleukin 12: still a promising candidate for tumor immunotherapy? | Cancer Immunol Immunother | 2014 | https://conductscience.org/library/papers/24514955 | PubMed |
| 23,645,882 | Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. | J Immunol | 2013 | https://conductscience.org/library/papers/23645882 | PubMed |
| 22,956,145 | Mouse models for tumor metastasis. | Methods Mol Biol | 2012 | https://conductscience.org/library/papers/22956145 | PubMed |
| 21,664,694 | Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression. | Mol Immunol | 2011 | https://conductscience.org/library/papers/21664694 | PubMed |
| 21,097,507 | Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21097507 | PubMed |
| 21,037,949 | Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression. | Curr Immunol Rev | 2005 | https://conductscience.org/library/papers/21037949 | PubMed |
| 20,362,661 | Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression. | Brain Behav Immun | 2010 | https://conductscience.org/library/papers/20362661 | PubMed |
| 19,554,267 | The influence of JNK and P38 MAPK inhibition on IL-12P40 and IL-23 production depending on IL12B promoter polymorphism. | Cell Mol Biol Lett | 2009 | https://conductscience.org/library/papers/19554267 | PubMed |
| 18,058,097 | Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/18058097 | PubMed |
| 16,794,636 | Photodynamic therapy and anti-tumour immunity. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16794636 | PubMed |
| 16,522,371 | Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation. | Cytokine | 2006 | https://conductscience.org/library/papers/16522371 | PubMed |
| 15,728,385 | Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15728385 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTGS2 | 5,743 | PubTator's text mining | https://conductscience.org/library/genes/5743 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15123779
GET https://conductscience.org/api/papers/v1/15123779/references?page=2